GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanai Health Industry Group Co Ltd (HKSE:01889) » Definitions » Enterprise Value

Sanai Health Industry Group Co (HKSE:01889) Enterprise Value : HK$-194.1 Mil (As of Jun. 06, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Sanai Health Industry Group Co Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Sanai Health Industry Group Co's Enterprise Value is HK$-194.1 Mil. Sanai Health Industry Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$26.7 Mil. Therefore, Sanai Health Industry Group Co's EV-to-EBIT ratio for today is -7.27.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Sanai Health Industry Group Co's Enterprise Value is HK$-194.1 Mil. Sanai Health Industry Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$26.7 Mil. Therefore, Sanai Health Industry Group Co's EV-to-EBITDA ratio for today is -7.27.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Sanai Health Industry Group Co's Enterprise Value is HK$-194.1 Mil. Sanai Health Industry Group Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$133.5 Mil. Therefore, Sanai Health Industry Group Co's EV-to-Revenue ratio for today is -1.45.


Sanai Health Industry Group Co Enterprise Value Historical Data

The historical data trend for Sanai Health Industry Group Co's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanai Health Industry Group Co Enterprise Value Chart

Sanai Health Industry Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 309.74 287.29 387.91 322.17 -84.34

Sanai Health Industry Group Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 387.91 279.01 322.17 121.29 -84.34

Competitive Comparison of Sanai Health Industry Group Co's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Sanai Health Industry Group Co's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanai Health Industry Group Co's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanai Health Industry Group Co's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Sanai Health Industry Group Co's Enterprise Value falls into.



Sanai Health Industry Group Co Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Sanai Health Industry Group Co's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

Sanai Health Industry Group Co's Enterprise Value for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanai Health Industry Group Co  (HKSE:01889) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Sanai Health Industry Group Co's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=-194.141/26.706
=-7.27

Sanai Health Industry Group Co's current Enterprise Value is HK$-194.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$26.7 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Sanai Health Industry Group Co's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=-194.141/26.706
=-7.27

Sanai Health Industry Group Co's current Enterprise Value is HK$-194.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$26.7 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Sanai Health Industry Group Co's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=-194.141/133.549
=-1.45

Sanai Health Industry Group Co's current Enterprise Value is HK$-194.1 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Sanai Health Industry Group Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$133.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sanai Health Industry Group Co Enterprise Value Related Terms

Thank you for viewing the detailed overview of Sanai Health Industry Group Co's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanai Health Industry Group Co (HKSE:01889) Business Description

Traded in Other Exchanges
Address
57 Hung To Road, Unit 5, 7th Floor, Nanyang Plaza, Kwun Tong, Kowloon, Hong Kong, HKG
Sanai Health Industry Group Co Ltd is a pharmaceutical company. The company has three reportable segments namely Pharmaceutical products includes development, manufacturing, marketing and sales of pharmaceutical products and related software and provision of consultancy services. Finance leasing includes the provision of financial leasing services; Genetic testing and molecular diagnostic services segment. It generates maximum revenue from Pharmaceutical products segments. Geographically, it derives a majority revenue from PRC.
Executives
Zhi Shaohuan 2101 Beneficial owner
Jiang Hengguang
Yang Youju 2201 Interest of corporation controlled by you
Yuan Chaoyang 2101 Beneficial owner
Cyber Success Global Investments Limited 2101 Beneficial owner

Sanai Health Industry Group Co (HKSE:01889) Headlines

No Headlines